Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 May 3.
Published in final edited form as: J Clin Pathol. 2009 Nov 25;63(4):337–340. doi: 10.1136/jcp.2009.070607

POSTMORTEM CANDIDEMIA: MARKER OF DISSEMINATED DISEASE

Jennifer L Thorn 1, Kevin B Gilchrist 1, Richard E Sobonya 1, Nand K Gaur 3, Peter N Lipke 4, Stephen A Klotz Klotz 2
PMCID: PMC3086197  NIHMSID: NIHMS288412  PMID: 19939858

Abstract

Aim

The significance of finding Candida species in heart blood cultures obtained at postmortem examination has never been studied. Therefore, we describe the findings of autopsy patients with postmortem candidemia and compare them to autopsy patients with antemortem candidemia.

Method

Twenty-three patients with Candida species isolated from heart blood at autopsy were identified over a ten-year period. These patients were compared to 10 autopsy patients found during the same time period with antemortem blood cultures isolating Candida species, but not positive postmortem heart blood cultures. Ante- and postmortem records were reviewed.

Results

All 23 patients with Candida species isolated from postmortem blood culture had one or more antemortem risk factors for disseminated candidiasis such as positive antemortem blood cultures, isolation of Candida from sterile internal sites, neutropenia, recent abdominal surgery, broadspectrum antibiotic administration or the use of central venous catheters or other invasive devices. Eight patients had histologic proof of invasive candidiasis in addition to the positive heart blood cultures. This group did not differ with respect to risk factors from 10 autopsy patients with disseminated candidiasis and antemortem blood cultures with Candida species. However, all the patients with antemortem candidemia had histologic evidence of disseminated candidiasis at autopsy.

Conclusion

Candidemia, when documented by heart blood culture performed at autopsy or by antemortem blood culture, is an insensitive, but highly specific indicator of disseminated candidiasis.

Keywords: Candida, disseminated candidiasis, candidemia, postmortem, autopsy

INTRODUCTION

Candida species are important opportunistic pathogens that can invade the vascular space giving rise to metastatic lesions in many organs (disseminated candidiasis).(1) A finding of Candida species in blood culture should prompt immediate empiric treatment and removal of central venous catheters as Candida species are no longer considered “contaminants” in blood culture.(2) However, postmortem studies of patients with hematological malignancies established that a significant number of patients with histological evidence of disseminated candidiasis did not have antemortem blood cultures with Candida species.(3, 4) Although the term disseminated candidiasis implies bloodborne spread of the microorganism to sterile sites, it is well accepted that in the case of Candida, antemortem blood culture is an insensitive indicator (~50%).(5) The, detection of these fungi in the blood is difficult and their presence in postmortem blood cultures has never been studied. We therefore studied 23 patients with postmortem candidemia to determine the significance of this finding.

METHODS

Postmortem examination

Patients with postmortem blood cultures with Candida were identified in a previous study of candidemia (6) approved by the University of Arizona Institutional Review Board. However, the patients with postmortem candidemia were not reported in that communication as the significance of the finding was unknown at the time. This led to the present investigation.

Postmortem evaluations were performed in the autopsy suite at the University Medical Center (UMC) in Tucson Arizona. Solid organ and bone marrow transplants are performed regularly at this center. Immunocompromised patients now constitute a large proportion of autopsy patients. Following review of the clinical record the body was opened utilizing a standard “Y” incision. The chest plate was removed exposing the organs of the thorax and lower neck. A dissection plane was exposed between the structures of the posterior mediastinum and the thoracic spine allowing an antero-infero removal of the thoracic block and visualization of the superior and inferior vena cava, as is standard in the En Bloc autopsy technique.(7)

Heart blood culture is standard procedure for all full autopsies performed at UMC. Using sterile technique a 20 cc. syringe with a 10-gauge needle was introduced into the lumen of the inferior vena cava and blood aspirated and injected into a BacT/Alert culture bottle (bioMerieux, Hazelwood, MO). Tissue sections of the lungs, liver, spleen and kidneys were obtained and processed in 4% neutral buffered formalin.

Histology

Hematoxylin-eosin (H&E) stained sections were examined for preliminary identification of fungal microorganisms. Gomori methenamine silver (GMS) staining was performed on the spleen, liver and kidney, to detect fungi. Two reviewers examined each H&E and GMS stained slide independently. Slides found positive for Candida species (presence of yeasts and/or pseudohyphae or true hyphae) were then examined by a third reviewer who confirmed or rejected the finding.

Microbiology

The BacT/Alert blood culture system was used. In early years of the study some blood culture isolates were identified as “yeasts not Candida albicans or Cryptococcus” because determining Candida species at that time was labor intensive and its significance in postmortem blood cultures, unappreciated. This designation was made after identifying yeasts on the gram stain of the blood culture, growing the yeast overnight on Sabouraud's agar and performing a germ tube test as well as a urea tube test to rule out Cryptococcus. The finding of “yeasts not Candida albicans or Cryptococcus” was therefore, virtually synonymous with “Candida species other than C. albicans.” This is confirmed by blood culture data. For example, from June 1997 through June 2006 there were 1164 blood cultures that isolated non-filamentous fungi. This represented 231 patients with Candida identified to species level. Ninety-four patients had C. albicans on blood culture and 137 that had non-albicans species. There were 4 patients with yeasts that could not be separated from Candida species using the tests outlined above, one with Hansenula polymorpha and one with Saccharomyces cerevisisiae. (Two patients were infected with Rhodotorula species, but these were identified by their production of pigment on Sabouraud's agar). Therefore, the likelihood that one of the “yeasts not Candida albicans or Cryptococcus” would be a Candida species (and not a confounder) is >60:1.

Culture of tissue such as lung for evidence of disseminated candidiasis was not utilized because of the lack of specificity of these cultures in the postmortem state. (8, 9)

RESULTS

General comments

From January 1997 to September 2008 there were 1655 partial or full autopsies performed and 39 autopsies (2%) noted candidemia, candidiasis or disseminated candidiasis in the formal autopsy report. Of these 39 individuals, 20 had histological evidence of disseminated candidiasis and of these, 10 had antemortem blood cultures that isolated Candida species. These 10 patients did not have postmortem heart blood cultures that isolated Candida species. However, 23 autopsy patients during this time period cultured Candida species from postmortem heart blood culture. Two of these patients had antemortem blood cultures that were positive for Candida species.

Patients ranged in age from stillborn to 90 years. Autopsy was performed from as short as 2 hours and twenty minutes to as long as 4.5 days following death (Table 1).

Table 1. Characteristics of patients with postmortem candidemia.

The results of microbiology and postmortem histology are included. Patients 14 and 15 and 19–23 had “yeasts not Candida albicans or Cryptococcus,” i.e., synonymous with Candida species not albicans.

Case Age/Sex Heart blood culture Risk for disseminated candidiasis Results of histological examination
1 3/F C. krusei; Enterococcus AL; neutropenia pseudo-membraneous colitis with invading yeasts
2 75/M C. albicans; Enterococcus; Xanthomonas AL; neutropenia
3 70/F C. albicans; S. aureus perforated viscus; peritonitis GMS: yeasts and filamentous forms perforating through the serosa
4 72/F C. albicans peritonitis yeasts in gastric wall and peritoneum
5 68/M C. albicans ruptured abdominal aorta; sepsis; abdominal surgery GMS: yeasts and pseudohyphae in spleen
6 79/M C. albicans surgical repair of ruptured thoracic and abdominal aorta
7 90/M C. albicans thoracic and abdominal aortic repair; necrotic colon; colectomy; DIC
8 Still born/F C. glabrata prematurity
9 4 days/F C. albicans high-risk twin; DIC; neonatal ICU for 4 days
10 5 mon ths/F C. albicans; CNS ischemic bowel; 75% removed
11 61/F C. pseudo-tropicalis and C. krusei widespread carcinomatosis of peritoneum; ascites; sepsis
12 54/F C. albicans diabetes; G.I. hemorrhage; pneumonia
13 65/F C. albicans severe C. difficile colitis; pneumonia
14 86/F yeast; CNS dead bowel; colectomy; abdominal surgery GMS: yeasts and pseudohyphae in spleen
15 75/F yeast G.I. ulcerations; pneumonia GMS: yeasts and pseudohyphae in spleen
16 50/F C. glabrata ESRD; gangrene of leg; pneumonia lung abscess with yeasts in lung and vascular tissue
17 52/M C. glabrata OHT; recurrent pneumonias
18 88/F C. glabrata pneumonia
19 73/M yeast; CNS AL; neutropenia; pneumonia
20 58/F yeast; Enterococcus peritonitis yeasts in muscle and bowel
21 72/F yeast; CNS metastatic pancreatic cancer
22 90/M yeast aspiration pneumonia; C. difficile colitis; ESRD
23 23/F yeast BMT; pneumonia

Abbreviations: G.I: gastrointestinal; BMT: bone marrow transplant; OHT: orthotopic heart transplant; CNS: coagulase-negative Staphylococcus; AL: acute leukemia; DIC: disseminated intravascular coagulation; ICU: intensive care unit; ESRD: end stage renal disease; GMS: Gomori methenamine silver stain.

Patients with Candida species in heart blood culture at postmortem

Patients had many comorbidities, some well known to predispose to disseminated candidiasis such as acute leukemia in three patients all of who had neutropenia induced by chemotherapy before death (patient #1,2,19) (Table 1). Additionally, patients #1 and 2 had positive antemortem blood cultures with C. krusei and C. albicans, respectively.

Sixteen of the patients received from one to four antibiotics before death. Six of the patients did not have medication records to review (they were from other hospitals) and one patient, a stillborn (patient # 8) did not receive antibiotics. Twenty-one patients had one or more central catheters or invasive tubes, which could have provided portals of entry of the fungus to the blood stream. Twelve Patients #3–7, 10–15 and 20 had likely gastrointestinal portals of entry of Candida (Table1). Three patients were pediatric cases (#8,9 and 10). Eight of 23 patients had histological evidence of invasive disseminated disease with Candida species.

Autopsy patients that had antemortem blood cultures, but not heart blood cultures that isolated Candida species

Only 10 of the 20 patients with evidence of disseminated candidiasis at autopsy had antemortem blood cultures with Candida species (similar to rates found in the past (3)) (Table 2). These patients as a group did not appear to have risk factors different than those with heart blood cultures that were positive at postmortem. However, all of the 10 patients had histological evidence of disseminated candidiasis.

Table 2. Characteristics of autopsy patients with antemortem candidemia.

The postmortem histology results are included. Postmortem heart blood cultures however, did not isolate Candida species from these patients.

Case Age/Sex Antemortem blood culture Risk for disseminated candidiasis Results of histological examination
1 Premature, 25 weeks /F C. albicans, E. coli, P. aeruginosa Prematurity Fungi invading myocardium, kidney, intestines
2 Premature, 29 weeks/F C. albicans, CNS Prematurity, hyaline membrane disease Twin of Case 1; fungal sepsis
3 10 years/M C. glabrata ALL, chemotherapy Fungi involved in erosive esophagitis
4 56 years/M C. albicans Severe erosive esophagitis and gastritis Fungi involved in erosive esophagitis and gastritis
5 3 years/M C. tropicalis ALL Fungal sepsis
6 24 years/M C. albicans Severe, erosive colitis Fungi involved in erosive colitis and pseudomembrane
7 20 years/M C. glabrata CML, chemotherapy, bone marrow transplant Fungi involved in pyelonephritis
8 74 years/M C. albicans Small bowel resection Fungi involved in pyelonephritis
9 3 years/M C. albicans, Enterococcus species HSCT Fungi involved in erosive colitis
10 29 years/M C. albicans, CNS Liver transplant Fungi invading myocardium, kidneys, adrenals, spleen, prostate

Abbreviations: ALL: acute lymphocytic leukemia; CML: chronic myelogenous leukemia; HSCT: hematopoetic stem cell transplantation; CNS: coagulase-negative Staphylococcus.

DISCUSSION

Postmortem blood cultures: colonization, contamination or pathogenicity?

Morris et al. in the most comprehensive study of the role of postmortem blood culture bacteriology (10) contends that there were four ways by which a positive blood culture could arise postmortem. First, a truly positive result, i.e., the microorganism invading in life and reaching target organs or fluids before death; second, agonal spread, microorganisms invading as the patient is in the process of dying where natural barriers are weakened by ischemia; third, postmortem translocation, e.g., from the gut to the blood in putrefying tissue. Fourth, is contamination of the specimen similar to that encountered with blood cultures antemortem. The authors concluded in a review of over 5000 autopsies that the second and third possibilities rarely occur (10) and that contamination (fourth possibility) may occur, but rates would likely be similar to those of antemortem blood cultures of 4–6%.(11) In conclusion, they regarded postmortem blood culture isolates as highly specific for disease.

Dolan et al. also concluded that agonal spread of microorganisms did not occur (12) and others point out that the positivity rate of postmortem blood cultures does not increase as a function of time after death and that postmortem blood cultures provide reliable cultures corresponding to antemortem disease.(13) Hove and Pencil concluded, like Morris et al., after comparing antemortem and postmortem blood cultures that the two were equivalent.(14) One study found an incidence of about 4% of postmortem heart blood cultures with C. albicans from 396 autopsies. (15)

Postmortem candidemia: A specific finding

Disseminated candidiasis remains a clinical diagnosis even in an era of powerful diagnostic tools.(5) Unfortunately blood culture is insensitive (~50%) and therefore other ancillary data must be brought to bear to establish the diagnosis antemortem.(5) The term disseminated candidiasis implies microorganism spread through the vascular system to sterile organs such as the kidneys, liver, spleen, retina and occasionally the heart valves and brain. However, unlike bacteremias, candidemia is difficult to detect and is not a constant feature of the illness although PCR may increase the sensitivity of documenting disease.(16) Maksymiuk et al. found that only 35% of 188 cancer patients with disseminated candidiasis at autopsy had antemortem blood cultures positive for Candida species.[3] The data from the two groups of autopsy patients reported here are very similar in respect to risk factors for disseminated candidiasis yet, one group (Table 1), had heart blood cultures positive at postmortem whereas the second group (Table 2) had antemortem blood cultures only that isolated Candida species. The only difference between the two groups was that those with positive antemortem blood cultures had histology that confirmed the disseminated nature of the disease. However, this is to be expected as the candidemia was present in detectable numbers for a longer time before death in those patients than in the patients with only postmortem blood cultures with Candida. Even so, there were two patients with postmortem candidemia that also had antemortem blood cultures that were positive for Candida species.

Results of pediatric autopsies also underscore the insensitivity of blood culture in disseminated candidiasis. Hughes, in a study of 109 fatal cases of candidiasis in children, found that 89% of the cases had more than one organ involved, yet antemortem blood cultures were of `limited diagnostic aid”.(17) Among 28 recent pediatric autopsies there were seven cases in which the autopsy findings would have altered the premortem care, the majority being due to Aspergillus and Candida that went undocumented by blood culture.(18) Disseminated candidiasis is common in neonates. In a report of 2027 neonatal autopsy cases, 6.6% of the cases had candidiasis.(19) This included 8 fetuses ranging in age from 22 to 40 weeks of which 5 cases had evidence of Candida in the brain, heart, lungs, liver, kidneys or intestines and the fungus was listed among the causes of death in all 8 cases. A study in Spain found that among 20,565 admissions to 27 different neonatal units, 118 or 0.57% of the total admissions had disseminated candidiasis, usually denoted as “sepsis”.(20)

The fact that many of the heart blood cultures were polymicrobial (9 of 23 or 39%) cannot be used as evidence of contamination. Polymicrobial blood cultures in which one microorganism is a Candida species is in fact, quite common (~20%) in the antemortem state [6] and therefore it would not be surprising to see a high incidence of polymicrobial blood cultures in postmortem blood cultures as well. The historical confusion about the meaning of finding yeasts in otherwise sterile tissue and blood culture carries over into the autopsy suite. As a recent example, an autopsy study found yeasts compatible with C. glabrata in the lungs and kidneys which was termed “transitory fungaemia”.(21) This type of categorization has no clinical correlate and most authorities would contend that the evidence represents disseminated candidiasis. Pathologists at our institution mentioned postmortem candidemia as possibly contributing to the death of only 7 of the 23 patients found to have Candida species in their postmortem heart blood cultures.

In conclusion this report demonstrates that postmortem candidemia is likely a reliable indicator of undetected premortem candidemia and may have contributed to the death of these patients. The 23 patients in our study had documented postmortem candidemia and multiple well known risk factors for candidemia including neutropenia, broadspectrum antibiotic use, the presence of central venous catheters or other invasive devices and recent abdominal surgery. Eight patients had postmortem histological evidence of dissemination. This group did not differ from 10 patients with antemortem candidemia.

The “take home message” is that postmortem candidemia is a reliable indicator of premortem candidemia and should be a part of the postmortem report.

Footnotes

The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd and its Licensees to permit this article (if accepted) to be published in JCP editions and any other BMJPGL products to exploit all subsidiary rights, as set out in our licence (http://group.bmj.com/products/journals/instructions-for-authors/licence-forms/).

Competing Interests: None to declare.

References

  • 1.Klotz SA. Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin Infect Dis. 1992;14:340–347. doi: 10.1093/clinids/14.1.340. [DOI] [PubMed] [Google Scholar]
  • 2.Pappas P, Rex J, Sobel J, Filler S, Dismukes W, Walsh T, et al. Infectious Diseases Society of America guidelines for treatment of candidiasis. Clin. Inf. Dis. 2004;38:161–189. doi: 10.1086/380796. [DOI] [PubMed] [Google Scholar]
  • 3.Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med. 1984;77:20–7. [PubMed] [Google Scholar]
  • 4.Bodey G, Nies B, Fririch E. Multiple organism septicemia in acute leukemia; analysis of 54 episodes. Arch Int Med. 1965;116:266–272. doi: 10.1001/archinte.1965.03870020106019. [DOI] [PubMed] [Google Scholar]
  • 5.Edwards JEJ. Candida species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. Elsevier Churchill Livingstone; Philadelphia, PA: 2005. pp. 2938–2957. [Google Scholar]
  • 6.Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diag Microbiol Inf Dis. 2007;59:401–406. doi: 10.1016/j.diagmicrobio.2007.07.001. [DOI] [PubMed] [Google Scholar]
  • 7.Collins K, Hutchins G. An introduction to autopsy technique. 2nd Edition CAP Press; Northfield, IL: 2005. [Google Scholar]
  • 8.el-Ebiary M, Torres A, Fabregas N, de la Bellacasa J, Gonzalez J, Ramirez J, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med. 1997;156:583–590. doi: 10.1164/ajrccm.156.2.9612023. [DOI] [PubMed] [Google Scholar]
  • 9.Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans W, et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med. 2009;35:1526–1531. doi: 10.1007/s00134-009-1482-8. [DOI] [PubMed] [Google Scholar]
  • 10.Morris J, Harrison L, Partridge S. Postmortem bacteriology: a re-evaluation. J Clin Pathol. 2006;59:1–9. doi: 10.1136/jcp.2005.028183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Weinstein M. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol. 2003;41:2275–2278. doi: 10.1128/JCM.41.6.2275-2278.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Dolan C, Brown AJ, Ritts R. Microbiology examination of postmortem tissues. Arch Pathol. 1971;92:206–211. [PubMed] [Google Scholar]
  • 13.Wood W, Oldstone M, Schultz R. A reevaluation of blood culture as an autopsy procedure. Amer J Clin Pathol. 1965;43:241–247. doi: 10.1093/ajcp/43.3.241. [DOI] [PubMed] [Google Scholar]
  • 14.Hove M, Pencil S. Effect of postmortem sampling technique on the clinical significance of autopsy blood cultures. Human Pathol. 1998;29:137–139. doi: 10.1016/s0046-8177(98)90223-4. [DOI] [PubMed] [Google Scholar]
  • 15.Koneman E, Davis M. Postmortem bacteriology. 3. Clinical significance of microorganisms recovered at autopsy. Am J Clin Pathol. 1974;61:28–40. doi: 10.1093/ajcp/61.1.28. [DOI] [PubMed] [Google Scholar]
  • 16.Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: Comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol. 2002;40:2483–2489. doi: 10.1128/JCM.40.7.2483-2489.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hughes W. Systemic candidiasis: a study of 109 fatal cases. Pediatr. Infect. Dis. 1982;1:11–18. [PubMed] [Google Scholar]
  • 18.Koszyca B, Moore L, Toogood I, Byard R. Is postmortem examination useful in pediatric oncology? Pediatr. Pathol. Pediatr. Pathol. 13:709–715. doi: 10.3109/15513819309048257. [DOI] [PubMed] [Google Scholar]
  • 19.Schwesinger G, Junghans D, Schroder G, Bernhardt H, Knoke M. Candidosis and aspergillosis as autopsy findings from 1994 to 2003. Mycoses. 2005;48:176–180. doi: 10.1111/j.1439-0507.2005.01101.x. [DOI] [PubMed] [Google Scholar]
  • 20.Lopez Sastre J, Coto Cotallo G, Fernadez Colomer B, GdH C. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatolo. 2003;20:153–163. doi: 10.1055/s-2003-40008. [DOI] [PubMed] [Google Scholar]
  • 21.Vennewald I, Seebacher C, Roitzsch E. Post-mortem findings in patients with repeadedly mycological demonstration of Candida glabrata. Mycoses. 1998;41:125–132. doi: 10.1111/j.1439-0507.1998.tb00313.x. [DOI] [PubMed] [Google Scholar]

RESOURCES